These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 30232187
1. Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells. Dominguez-Molina B, Machmach K, Perales C, Tarancon-Diez L, Gallego I, Sheldon JL, Leal M, Domingo E, Ruiz-Mateos E. J Virol; 2018 Dec 01; 92(23):. PubMed ID: 30232187 [Abstract] [Full Text] [Related]
7. IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells. Zhang S, Saha B, Kodys K, Szabo G. J Hepatol; 2013 Sep 01; 59(3):442-9. PubMed ID: 23665181 [Abstract] [Full Text] [Related]
8. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. Dolganiuc A, Chang S, Kodys K, Mandrekar P, Bakis G, Cormier M, Szabo G. J Immunol; 2006 Nov 15; 177(10):6758-68. PubMed ID: 17082589 [Abstract] [Full Text] [Related]
9. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus. Sacre K, Criswell LA, McCune JM. Arthritis Res Ther; 2012 Jun 27; 14(3):R155. PubMed ID: 22734582 [Abstract] [Full Text] [Related]
11. Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state. Kaushik S, Teque F, Patel M, Fujimura SH, Schmidt B, Levy JA. AIDS Res Hum Retroviruses; 2013 Mar 27; 29(3):501-10. PubMed ID: 23131038 [Abstract] [Full Text] [Related]
13. Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation. Gujer C, Sundling C, Seder RA, Karlsson Hedestam GB, Loré K. Immunology; 2011 Nov 27; 134(3):257-69. PubMed ID: 21977996 [Abstract] [Full Text] [Related]
14. HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells. Saïdi H, Bras M, Formaglio P, Melki MT, Charbit B, Herbeuval JP, Gougeon ML. PLoS Pathog; 2016 Feb 27; 12(2):e1005407. PubMed ID: 26871575 [Abstract] [Full Text] [Related]
15. Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line. Wang Y, Li J, Wang X, Ye L, Zhou Y, Thomas RM, Ho W. Innate Immun; 2014 Jan 27; 20(1):3-11. PubMed ID: 23529855 [Abstract] [Full Text] [Related]
16. Cross-linking of CD81 by HCV-E2 protein inhibits human intrahepatic plasmacytoid dendritic cells response to CpG-ODN. Tu Z, Zhang P, Li H, Niu J, Jin X, Su L. Cell Immunol; 2013 Jan 27; 284(1-2):98-103. PubMed ID: 23954883 [Abstract] [Full Text] [Related]
17. Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells. Vincent IE, Zannetti C, Lucifora J, Norder H, Protzer U, Hainaut P, Zoulim F, Tommasino M, Trépo C, Hasan U, Chemin I. PLoS One; 2011 Jan 27; 6(10):e26315. PubMed ID: 22046272 [Abstract] [Full Text] [Related]
18. TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity. Kalb ML, Glaser A, Stary G, Koszik F, Stingl G. J Immunol; 2012 Feb 15; 188(4):1583-91. PubMed ID: 22231699 [Abstract] [Full Text] [Related]
19. Human Immunodeficiency Virus-1 Impairs IFN-Alpha Production Induced by TLR-7 Agonist in Plasmacytoid Dendritic Cells. Dhamanage A, Thakar M, Paranjape R. Viral Immunol; 2017 Feb 15; 30(1):28-34. PubMed ID: 27809682 [Abstract] [Full Text] [Related]
20. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation. Gotoh K, Tanaka Y, Nishikimi A, Nakamura R, Yamada H, Maeda N, Ishikawa T, Hoshino K, Uruno T, Cao Q, Higashi S, Kawaguchi Y, Enjoji M, Takayanagi R, Kaisho T, Yoshikai Y, Fukui Y. J Exp Med; 2010 Apr 12; 207(4):721-30. PubMed ID: 20231379 [Abstract] [Full Text] [Related] Page: [Next] [New Search]